Table 7.

Multivariate logistic regression analysis of influencing factors of FMD improvement at 1-year follow-up

	B	S.E.	Wald	P	Exp (B)	95% CI
Male gender	−1.126	1.163	0.937	0.333	0.324	0.033–3.171
Age ≥ 65 years	1.798	0.938	3.673	0.055	6.038	0.960–37.974
Family history of premature cardiovascular diseases	−0.691	0.849	0.661	0.416	0.501	0.095–2.648
Smoking	−0.176	0.975	0.033	0.856	0.838	0.124–5.666
Systolic blood pressure	0.041	0.025	2.793	0.095	1.042	0.993–1.094
Low-density lipoprotein cholesterol	−0.471	0.687	0.470	0.493	0.625	0.163–2.400
Serum creatine	−0.089	0.042	4.479	0.034	0.915	0.843–0.993
HbA1c ≥ 6.5%	−0.686	0.518	1.754	0.185	0.503	0.182–1.390
Endothelial progenitor cells	0.099	0.027	13.295	0.000	1.104	1.047–1.165
Constant	3.208	5.772	0.309	0.578	24.725

FMD flow-mediated dilatation